144 related articles for article (PubMed ID: 37442620)
1. Recovery from Traumatic Brain Injury Is Nociceptin/Orphanin FQ Peptide Receptor Genotype-, Sex-, and Injury Severity-Dependent.
Al Yacoub ON; Awwad HO; Standifer KM
J Pharmacol Exp Ther; 2024 Apr; 389(2):136-149. PubMed ID: 37442620
[TBL] [Abstract][Full Text] [Related]
2. Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours.
Al Yacoub ON; Zhang Y; Patankar PS; Standifer KM
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338936
[TBL] [Abstract][Full Text] [Related]
3. Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.
Awwad HO; Durand CD; Gonzalez LP; Tompkins P; Zhang Y; Lerner MR; Brackett DJ; Sherry DM; Awasthi V; Standifer KM
Behav Brain Res; 2018 Mar; 340():183-194. PubMed ID: 27793733
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder.
Zhang Y; Schalo I; Durand C; Standifer KM
Front Psychiatry; 2018; 9():731. PubMed ID: 30670988
[TBL] [Abstract][Full Text] [Related]
5. The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury.
Al Yacoub ON; Tarantini S; Zhang Y; Csiszar A; Standifer KM
Front Pharmacol; 2023; 14():1272969. PubMed ID: 37920208
[TBL] [Abstract][Full Text] [Related]
6. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities.
Al Yacoub ON; Awwad HO; Zhang Y; Standifer KM
Pharmacol Ther; 2022 Mar; 231():107982. PubMed ID: 34480968
[TBL] [Abstract][Full Text] [Related]
9. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
Sinchak K; Romeo HE; Micevych PE
J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
Green MK; Devine DP
Neuropeptides; 2009 Dec; 43(6):507-14. PubMed ID: 19720395
[TBL] [Abstract][Full Text] [Related]
12. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
Aujla H; Cannarsa R; Romualdi P; Ciccocioppo R; Martin-Fardon R; Weiss F
Addict Biol; 2013 May; 18(3):467-79. PubMed ID: 22804785
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
14. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons.
Anand P; Yiangou Y; Anand U; Mukerji G; Sinisi M; Fox M; McQuillan A; Quick T; Korchev YE; Hein P
Pain; 2016 Sep; 157(9):1960-1969. PubMed ID: 27127846
[TBL] [Abstract][Full Text] [Related]
16. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.
Depner UB; Reinscheid RK; Takeshima H; Brune K; Zeilhofer HU
Eur J Neurosci; 2003 Jun; 17(11):2381-7. PubMed ID: 12814369
[TBL] [Abstract][Full Text] [Related]
17. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
Thomas RC; Bath MF; Stover CM; Lambert DG; Thompson JP
Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013
[TBL] [Abstract][Full Text] [Related]
18. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies.
Rizzi A; Molinari S; Marti M; Marzola G; Calo' G
Neuropharmacology; 2011 Mar; 60(4):572-9. PubMed ID: 21184763
[TBL] [Abstract][Full Text] [Related]
20. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
Liao YY; Lee CW; Ho IK; Chiou LC
Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
